Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report.

Saved in:
Bibliographic Details
Title: Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report.
Authors: Lui SW; School of Medicine, National Defense Medical Center, Taipei, Taiwan, R.O.C., Lu JW; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.; The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Ho YJ; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C., Tang SE; Division of Pulmonary and Critical Care, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan, R.O.C., Ko KH; Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C., Hsieh TY; School of Medicine, National Defense Medical Center, Taipei, Taiwan, R.O.C., Liu FC; Rheumatology/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C. lfc10399@yahoo.com.tw.
Source: In vivo (Athens, Greece) [In Vivo] 2024 May-Jun; Vol. 38 (3), pp. 1512-1518.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1791-7549
DOI:10.21873/invivo.13600